TrialAI-Lab
Clinical-trial intelligence for feasibility, completion risk, eligibility criteria NLP, adverse-event signals, trial similarity, and time-to-completion analysis.
TrialAI-Lab analyzes public clinical trial data to study trial completion, early termination, feasibility, eligibility criteria, adverse-event signals, trial similarity, and time-to-completion.
The system combines structured trial metadata, clinical evidence, and machine learning evaluation to support feasibility and development questions.
The recovered validation suite now includes random and chronological holdouts, an uncached ClinicalTrials.gov extension, and an AACT flat-file snapshot with modeling-cache trial IDs excluded. The AACT evaluation is registry-derived and is not represented as independent clinical-source validation.
Clinical deployment note
These system pages describe technical capabilities and evaluation workflows. Any diagnostic, treatment, or patient-specific use would require appropriate validation, governance, and regulatory review.